FDANonrulemakingFDA-2022-D-0697

Who commented on this docket

Sameness Evaluations in an Abbreviated New Drug Application – Active Ingredients; Draft Guidance for Industry; Availability

1 organizations filed 1 public comment on Sameness Evaluations in an Abbreviated New Drug Application – Active Ingredients; Draft Guidance for Industry; Availability, at the Food and Drug Administration. The comment window closed 1296d ago.

Organizations
1
Comments
1
RIN
Comment window
closed 1296d ago

Abstract

OPEN

Commenters (1)

View this docket on regulations.gov →

Attribution is name-based and imperfect. regulations.gov data is public record.